Company Filing History:
1 out of 169 
1 out of 893 
1 out of 3,539 
Years Active: 2019
Title: Rakefet Czernimski: Innovator in Sustained Release Drug Delivery Systems
Introduction
Rakefet Czernimski is a notable inventor based in Mevaseret Tzion, Israel. She has made significant contributions to the field of medical research, particularly in the development of drug delivery systems aimed at treating head and neck cancers. Her innovative approach has the potential to improve therapeutic outcomes for patients suffering from these conditions.
Latest Patents
Czernimski holds a patent for a "Sustained release delivery system for the prevention and treatment of head and neck cancers." This invention discloses a method for treating head and neck cancer or preventing the development of pre-malignant lesions. The system involves administering a sustained release drug delivery system locally to the oral cavity, which remains attached for at least one hour while releasing the drug to maintain an effective therapeutic concentration.
Career Highlights
Throughout her career, Rakefet Czernimski has worked with prominent organizations such as Hadasit Medical Research Services and Development Ltd. and Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Her work has been instrumental in advancing research in the medical field, particularly in cancer treatment.
Collaborations
Czernimski has collaborated with esteemed colleagues, including Michael M. Friedman and Silvio Gutkind. These partnerships have contributed to her innovative research and the development of effective treatment methodologies.
Conclusion
Rakefet Czernimski's contributions to the field of drug delivery systems exemplify her commitment to improving cancer treatment. Her innovative patent and collaborative efforts highlight her role as a leading inventor in medical research.